CBL
Cannabicyclol · CBL · Discovered 1967
Explore CBL (Cannabicyclol), a rare non-psychoactive cannabinoid formed from the photochemical degradation of CBC. Learn about its unique formation pathway, limited research, and what is known about its properties.
Psychoactive
No
Discovered
1967
Effects
3 documented
Benefits
1 studied
Overview
Cannabicyclol (CBL) is a rare, non-psychoactive cannabinoid that forms through the photochemical conversion (light-induced degradation) of cannabichromene (CBC). When CBC is exposed to ultraviolet light or acidic conditions, its open chromene ring system undergoes a photochemical cyclization to form the cyclopropane ring characteristic of CBL. This makes CBL analogous to CBN in that both are degradation products of more abundant cannabinoids — CBN from THC oxidation, and CBL from CBC photodegradation.
CBL was first identified in cannabis in 1967 and is typically found in very low concentrations in fresh cannabis. However, aged cannabis that has been exposed to significant light can contain higher levels of CBL as its CBC content converts over time. Like many rare cannabinoids, CBL has received minimal research attention, and its pharmacological profile remains largely uncharacterized.
The extremely limited research on CBL makes it difficult to assess its therapeutic potential. Unlike CBN, which has at least some preclinical data supporting various therapeutic claims, CBL lacks even this basic foundation of scientific evidence. As analytical methods improve and the cannabis industry's interest in rare cannabinoids grows, CBL may eventually receive the research attention needed to determine whether it has any unique therapeutic properties or whether it is pharmacologically inert.
Mechanism of Action
CBL's mechanism of action is essentially unknown. Its cyclopropane ring structure differentiates it significantly from most other cannabinoids and likely alters its receptor binding characteristics. Very limited data suggests CBL does not interact significantly with CB1 or CB2 receptors, consistent with its non-psychoactive status. No published research has systematically evaluated CBL's interaction with TRP channels, serotonin receptors, PPARs, or other common cannabinoid targets. The compound's unique ring structure could potentially confer novel receptor interactions, but this remains speculative without experimental data.
Therapeutic Effects
Potential Benefits
Unknown — Research Needed
No published preclinical or clinical studies have evaluated CBL for any specific therapeutic application. Its unique cyclopropane structure could theoretically confer interesting biological activity, but this is purely speculative. CBL represents a significant research gap in cannabinoid science.
Side Effects & Risks
- ⚠No side effects documented due to absence of research
- ⚠Safety profile completely unknown
- ⚠Not available in sufficient quantities for practical use or assessment
Concentration & Sources
Typical Concentration
Trace amounts in most cannabis; potentially higher in aged, light-exposed material where CBC has degraded; not commercially available as an isolated product
Found In
Aged cannabis exposed to UV light (converted from CBC). Trace amounts in various cannabis cultivars. Not commercially available as an isolated product.
Legal Status
Not specifically regulated or scheduled. Legal in most jurisdictions as a non-psychoactive, naturally occurring minor cannabinoid.
Research Summary
CBL is one of the most under-researched cannabinoids known to science. Since its identification in 1967, virtually no pharmacological, toxicological, or therapeutic research has been published on this compound. This research gap exists because CBL occurs in very low concentrations, is difficult to isolate, and has not been the focus of any known drug development program. Its status as a photodegradation product of CBC — itself an under-studied cannabinoid — has further limited scientific interest. As the field of cannabinoid science expands beyond THC and CBD, compounds like CBL may eventually receive systematic investigation, but currently there is insufficient evidence to make any claims about its biological activity or therapeutic potential.
Related Cannabinoids
CBL FAQ
What is CBL?
CBL (cannabicyclol) is a rare, non-psychoactive cannabinoid that forms when CBC (cannabichromene) is exposed to UV light or acidic conditions. It is a photodegradation product rather than a compound directly synthesized by the cannabis plant. CBL is found in very low concentrations in cannabis and is one of the least studied cannabinoids in the scientific literature.
Does CBL have any effects?
The effects of CBL are essentially unknown due to a near-total absence of published research. CBL does not produce psychoactive effects, which is the one property that can be stated with reasonable confidence based on its structural characteristics and limited testing. Whether CBL has any therapeutic properties — anti-inflammatory, analgesic, or otherwise — cannot be determined from the current evidence base.
How is CBL formed?
CBL forms through the photochemical conversion of CBC (cannabichromene) when exposed to ultraviolet light. The UV radiation causes CBC's chromene ring to undergo cyclization, creating the cyclopropane ring structure characteristic of CBL. This is why aged cannabis stored in light-exposed conditions may contain higher CBL levels as its CBC content degrades over time. CBL can also form under acidic conditions.
Is CBL legal?
CBL is not specifically regulated or scheduled in any jurisdiction. As a non-psychoactive, naturally occurring cannabis compound found only in trace amounts, it falls outside the scope of controlled substance laws. CBL is legal wherever cannabis-derived products are permitted and poses no regulatory concerns.
Continue Exploring
Disclaimer: Cannabinoid information is provided for educational purposes only. Medical benefits are based on published research and are not intended as medical advice. Individual responses to cannabinoids vary. Always consult a healthcare professional before using cannabis for medical purposes. Legal status information is current as of publication but may change — verify your local laws.